Nuformix Plc (GB:NFX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Nuformix Plc confirms its total voting rights, following the issuance of new shares, with a total of 1,419,309,368 ordinary shares in circulation, each holding one vote. This information is crucial for shareholders to calculate their notification requirements under FCA rules. Nuformix, a pharmaceutical company focusing on fibrosis and oncology, aims to innovate through drug repurposing, offering new commercial opportunities.
For further insights into GB:NFX stock, check out TipRanks’ Stock Analysis page.